Literature DB >> 15289308

p53 upregulates death receptor 4 expression through an intronic p53 binding site.

Xiangguo Liu1, Ping Yue, Fadlo R Khuri, Shi-Yong Sun.   

Abstract

Death receptor 4 (DR4) is one of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors and triggers apoptosis on ligation with TRAIL or overexpression. Our previous study demonstrated that DR4 expression could be regulated in a p53-dependent fashion. In the present study, we have demonstrated that DR4 is a p53 target gene and is regulated by p53 through a functional intronic p53 binding site (p53BS) based on the following lines of evidence: (a) the p53BS in the DR4 gene is almost identical to the one found in the first intron of the DR5 gene in terms of their locations and sequences; (b) DR4 p53BS bound to p53 protein in intact cells upon p53 activation as demonstrated by a chromatin immunoprecipitation assay; (c) a luciferase reporter vector carrying the DR4 p53BS upstream of an SV40 promoter exhibited enhanced luciferase activity when transiently cotransfected with a wild-type p53 expression vector in p53-null cell lines or stimulated with DNA-damaging agents in a cell line having wild-type p53; and (d) when the DR4 p53BS, together with its own corresponding promoter region in the same orientation as it sits in its natural genomic locus, was cloned into a basic luciferase vector without a promoter element, its transcriptional activity was strikingly increased by cotransfection of a wild-type p53 expression vector or treatment with DNA-damaging agents. However, wild-type p53 or DNA-damaging agents completely lost their activity to increase transcriptional activity of a reporter construct with deleted DR4 p53BS. Thus, we conclude that p53 directly regulates the expression of the DR4 gene via the novel intronic p53BS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289308     DOI: 10.1158/0008-5472.CAN-04-1195

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

Review 1.  Resistance to TRAIL and how to surmount it.

Authors:  Danijela Maksimovic-Ivanic; Stanislava Stosic-Grujicic; Ferdinando Nicoletti; Sanja Mijatovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 2.  Apoptosis: a mechanism of acute and chronic liver injury.

Authors:  M E Guicciardi; G J Gores
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

3.  E2 ligase dRad6 regulates DMP53 turnover in Drosophila.

Authors:  Su Chen; Hui-Min Wei; Wen-Wen Lv; Da-Liang Wang; Fang-Lin Sun
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

4.  Regulation in the targeting of TRAIL receptor 1 to cell surface via GODZ for TRAIL sensitivity in tumor cells.

Authors:  Y Oh; Y-J Jeon; G-S Hong; I Kim; H-N Woo; Y-K Jung
Journal:  Cell Death Differ       Date:  2012-01-13       Impact factor: 15.828

5.  Regulation of endothelial nitric oxide synthase by small RNA.

Authors:  Ming-Xiang Zhang; Hesheng Ou; Ying H Shen; Jing Wang; Jian Wang; Joseph Coselli; Xing Li Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

6.  Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53.

Authors:  Khondoker M Akram; Nicola J Lomas; Nicholas R Forsyth; Monica A Spiteri
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

7.  Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition.

Authors:  Weilong Yao; You-Take Oh; Jiusheng Deng; Ping Yue; Liang Deng; Henry Huang; Wei Zhou; Shi-Yong Sun
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

8.  Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.

Authors:  Dolly G Aguilera; Chandra M Das; Neeta D Sinnappah-Kang; Celine Joyce; Pete H Taylor; Sijin Wen; Martin Hasselblatt; Werner Paulus; Greg Fuller; Johannes E Wolff; Vidya Gopalakrishnan
Journal:  J Neurooncol       Date:  2009-01-16       Impact factor: 4.130

Review 9.  TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.

Authors:  Peter A Holoch; Thomas S Griffith
Journal:  Eur J Pharmacol       Date:  2009-10-18       Impact factor: 4.432

10.  The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts.

Authors:  Patrick Dumont; Laurent Ingrassia; Sébastien Rouzeau; Fabrice Ribaucour; Stéphanie Thomas; Isabelle Roland; Francis Darro; Florence Lefranc; Robert Kiss
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.